首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 再生醫學細胞療法基因療法

市場調查報告書

商品編碼

1361767

全球細胞和基因治療臨床試驗市場報告

Global Cell And Gene Therapy Clinical Trials Market Report

出版日期: 2023年10月01日 | 出版商:

Value Market Research | 英文 127 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球細胞和基因療法臨床試驗市場的需求預計將從 2022 年的 97.2 億美元達到 2030 年的近 529.3 億美元，2023-2030 年研究期間年複合成長率為 20.72%。

細胞和基因療法臨床試驗已迅速成為生物製藥領域最具變革性的創新之一。 CGT 在超越其最初腫瘤學重點的治療領域進行了測試，包括神經病學和眼科治療。細胞和基因治療臨床試驗掀起了生命科學產業的新一波創新浪潮。

市場動態：

CGT管道的增加是推動市場成長率的根本原因。此外，增加資金、研發投資以及成功的產品發布正在推動市場成長。此外，細胞和基因療法臨床試驗市場在過去幾年中出現了顯著成長，製藥公司合作為患者創造有效且易於使用的療法。此外，細胞和基因治療的臨床研究與去年相比顯著增加，因為研究人員現在將重點轉向基因治療，因為它具有治療癌症或罕見疾病的潛力。這種轉變預計將推動市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞和基因治療臨床試驗市場的各個部分進行了包容性評估。細胞和基因治療臨床試驗產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的細胞和基因治療臨床試驗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞和基因治療臨床試驗市場的主要參與者包括 IQVIA、ICON Plc、Laboratory Corporation of America Holdings、Charles River Laboratories International, Inc.、PAREXEL International Corp.、Syneos Health、Medpace, Holdings, Inc.、PPD Inc.。、Novotech、Veristat LLC。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：細胞與基因療法臨床試驗公司的競爭格局

細胞與基因治療臨床試驗市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
IQVIA

公司簡介
公司收入
產品
最近的發展

ICON Plc

公司簡介
公司收入
產品
最近的發展

Laboratory Corporation of America Holdings

公司簡介
公司收入
產品
最近的發展

Charles River Laboratories International Inc.

公司簡介
公司收入
產品
最近的發展

PAREXEL International Corp.

公司簡介
公司收入
產品
最近的發展

Syneos Health

公司簡介
公司收入
產品
最近的發展

Medpace

公司簡介
公司收入
產品
最近的發展

Holdings Inc.

公司簡介
公司收入
產品
最近的發展

PPD Inc.

公司簡介
公司收入
產品
最近的發展

Novotech

公司簡介
公司收入
產品
最近的發展

Veristat LLC

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218697

The global demand for Cell And Gene Therapy Clinical Trials Market is presumed to reach the market size of nearly USD 52.93 BN by 2030 from USD 9.72 BN in 2022 with a CAGR of 20.72% under the study period 2023 - 2030.

Cell and gene therapies clinical trials have quickly emerged as one of the most transformative innovations in biopharmaceuticals. CGTs are tested in therapeutic areas beyond their initial oncology focus, including neurology and ophthalmology treatment. Cell and gene therapy clinical trials present a new wave of innovation in the life sciences industry.

MARKET DYNAMICS:

The rise in the CGT pipeline is the root cause fuelling the market growth rate. Also, increasing funding, investments in research and development, and successful product launches are boosting the market growth. Moreover, the market of cell and gene therapy clinical trials has witnessed significant growth over the past few years, with pharma firms partnering to create effective and accessible therapies for patients. Furthermore, cell and gene therapy clinical studies increased significantly compared to last year, as researchers are now shifting their focus to gene therapy because of its potential to treat cancer or rare diseases. This shift is expected to fuel the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell and gene therapy clinical trials. The growth and trends of cell and gene therapy clinical trials industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell and gene therapy clinical trials market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Phase

Phase I
Phase II
Phase III
Phase IV

By Indication

Oncology
Cardiology
CNS
Musculoskeletal
Infectious Diseases
Dermatology
Endocrine, Metabolic, Genetic
Immunology & Inflammation
Ophthalmology
Hematology
Gastroenterology
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell And Gene Therapy Clinical Trials market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell and gene therapy clinical trials market include IQVIA, ICON Plc, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., PAREXEL International Corp., Syneos Health, Medpace, Holdings, Inc., PPD Inc., Novotech, Veristat LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CELL AND GENE THERAPY CLINICAL TRIALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Phase
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CELL AND GENE THERAPY CLINICAL TRIALS MARKET ANALYSIS BY PHASE

6.1 Overview by Phase
6.2 Historical and Forecast Data
6.3 Analysis by Phase
6.4 Phase I Historic and Forecast Sales by Regions
6.5 Phase II Historic and Forecast Sales by Regions
6.6 Phase III Historic and Forecast Sales by Regions
6.7 Phase IV Historic and Forecast Sales by Regions

7 . GLOBAL CELL AND GENE THERAPY CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

7.1 Overview by Indication
7.2 Historical and Forecast Data
7.3 Analysis by Indication
7.4 Oncology Historic and Forecast Sales by Regions
7.5 Cardiology Historic and Forecast Sales by Regions
7.6 CNS Historic and Forecast Sales by Regions
7.7 Musculoskeletal Historic and Forecast Sales by Regions
7.8 Infectious Diseases Historic and Forecast Sales by Regions
7.9 Dermatology Historic and Forecast Sales by Regions
7.10. Endocrine, Metabolic, Genetic Historic and Forecast Sales by Regions
7.11 Immunology & Inflammation Historic and Forecast Sales by Regions
7.12 Ophthalmology Historic and Forecast Sales by Regions
7.13 Hematology Historic and Forecast Sales by Regions
7.14 Gastroenterology Historic and Forecast Sales by Regions
7.15 Others Historic and Forecast Sales by Regions

8 . GLOBAL CELL AND GENE THERAPY CLINICAL TRIALS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL AND GENE THERAPY CLINICAL TRIALS COMPANIES

9.1. Cell And Gene Therapy Clinical Trials Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CELL AND GENE THERAPY CLINICAL TRIALS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. IQVIA
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. ICON Plc
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Laboratory Corporation of America Holdings
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Charles River Laboratories International Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. PAREXEL International Corp.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Syneos Health
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Medpace
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Holdings Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. PPD Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Novotech
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Veristat LLC
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments